Detalhe da pesquisa
1.
S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification.
Proc Natl Acad Sci U S A
; 113(5): 1351-6, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26787880
2.
Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction.
Mol Pharmacol
; 89(1): 176-86, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26494861
3.
Sphingosine 1-phosphate receptor 1 (S1P(1)) upregulation and amelioration of experimental autoimmune encephalomyelitis by an S1P(1) antagonist.
Mol Pharmacol
; 83(2): 316-21, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23204443
4.
Real-time differential labeling of blood, interstitium, and lymphatic and single-field analysis of vasculature dynamics in vivo.
Am J Physiol Cell Physiol
; 302(10): C1460-8, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357735
5.
S1P(1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis.
Mol Pharmacol
; 81(2): 166-74, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031473
6.
Modulation of chemokines and allergic airway inflammation by selective local sphingosine-1-phosphate receptor 1 agonism in lungs.
Mol Pharmacol
; 79(1): 61-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20935081
7.
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).
J Med Chem
; 62(4): 1761-1780, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707578
8.
Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
Mol Pharmacol
; 74(5): 1308-18, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18708635